Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Ling Chun Chen
(Contributor)
Shyr-Yi Lin
(Contributor)
Ming-Thau Sheu
(Contributor)
Yuan-Soon Ho
(Contributor)
Chia Yu Su
(Contributor)
Michael Chen
(Contributor)
Hsiu-O Ho
(Contributor)
Kuo-Hsiang Chuang
(Contributor)
Taipei Municipal Wanfang Hospital
TMU Research Center of Cancer Translational Medicine
Executive Master Program of Business Administration in Biotechnology (EMBA)
Graduate Institute of Clinical Medicine
Department of General Medicine
Master Program in Clinical Genomics and Proteomics
Department of Pharmaceutical Sciences
School of Medical Laboratory Science and Biotechnology
International Master/Ph.D. Program in Medicine
The Ph.D. Program for Translational Medicine
Ph.D. Program in Medical Neuroscience
Ph.D. Program for Cancer Molecular Biology and Drug Discovery
Ph.D. Program in Medical Biotechnology
Graduate Institute of Pharmacognosy
Ph.D. Program in Drug Discovery and Development Industry
TMU Research Center of Drug Discovery
Ph. D. Program in the Clinical Drug Development of Herbal Medicine
Dataset
Overview
Research output
(1)
Research output
Research output per year
2018
2018
2018
1
Article
Research output per year
Research output per year
1 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Filter
Article
Search results
2018
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Su, C. Y., Chen, M., Chen, L. C., Ho, Y. S.,
Ho, H. O.
,
Lin, S. Y.
,
Chuang, K. H.
& Sheu, M. T.,
Nov 1 2018
,
In:
Drug Delivery.
25
,
1
,
p. 1066-1079
14 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
Egg Lecithin
100%
Bispecific Antibody
100%
Docetaxel
100%
Nanocarrier
100%
Epidermal Growth Factor Receptor 2
100%
19
Citations (Scopus)